Parameter | Low MACC-1 Expression n = 17 | High MACC-1 Expression n = 29 | P value |
Age | 45.6 ± 11.82 | 58.5 ± 14.84 | <0.05 |
Gender |
| ||
Male(n = 31) | 35.5% (11/31) | 64.5% (20/31) | NS |
Female (n = 15) | 40% (6/15) | 60% (9/15) | |
Location |
| ||
Cardia (n = 9) | 33.3% (3/9) | 66.7% (6/9) | NS |
Body (n = 17) | 35.3% (6/17) | 64.7% (11/17) | |
Antrum (n = 20) | 40% (8/20) | 60% (12/20) | |
Tumor size |
| ||
<5 cm (n = 19) | 63.2% (12/19) | 36.8% (7/19) | <0.05 |
≥5 cm (n = 27) | 18.5% (5/27) | 81.5% (22/27) | |
Histological classification |
| ||
Papillary adenocarcinoma (n = 7) | 28.6% (2/7) | 71.4% (5/7) | NS |
Tubular adenocarcinoma (n = 22) | 36.4% (8/22) | 63.6% (14/22) | |
Mucinous adenocarcinoma (n = 8) | 37.5% (3/8) | 62.5% (5/8) | |
Signet-ring cell carcinoma (n = 9) | 44.4% (4/9) | 55.6% (5/9) | |
Invasion depth |
| ||
T 1,2 (n = 18) | 66.7% (12/18) | 33.3% (6/18) | <0.05 |
T 3,4 (n = 28) | 17.9% (5/28) | 82.1% (23/28) | |
LN involvement |
| ||
NO (n = 14) | 71.4% (10/14) | 28.6% (4/14) | <0.05 |
YES (n = 32) | 21.9% (7/32) | 78.1% (25/32) | |
Distant metastasis |
| ||
M0 (n = 32) | 43.7% (16/32) | 50% (16/32) | <0.05 |
M1 (n = 14) | 7.1% (1/14) | 92.9% (13/14) | |
TNM stages |
| ||
I, II (n = 16) | 68.7% (11/16) | 31.3% (5/16) | <0.05 |
III, IV (n = 30) | 20% (6/30) | 80% (24/30) |